Mark Bissue

network admin at Mabtech AB - Nacka Strand, Stockholm, Sw

Mark Bissue's Contact Details
HQ
N/A
Location
Ghana
Company
Mabtech AB
Mark Bissue's Company Details
Mabtech AB logo, Mabtech AB contact details

Mabtech AB

Nacka Strand, Stockholm, Sw • 100 - 249 Employees
Market Research

Capture | Detect | DiscoverMabtech is a Swedish biotech company founded in 1986. Our mission is to aid researchers to reach new frontiers and develop novel therapies, by supplying optimal immunoassays based on high-quality monoclonal antibodies and instruments. We develop and produce a wide range of monoclonal antibodies to cytokines and immunoglobulins. By selecting optimal matching pairs of capture and detection antibodies, we develop dependable sandwich assays such as ELISA, ELISpot and FluoroSpot kits. These kits are used to study immune responses in e.g. infectious disease, cancer, allergy, transplantation and as monitoring tools in vaccine trials. Our readers deliver unbiased spot analysis by combining an innovative algorithm with state-of-the-art hardware. Mabtech IRIS is our next-generation 4-color FluoroSpot/ELISpot reader enabling reliable multiplexing. Mabtech ASTOR is a reader with the same innovative and user-friendly technology for labs performing only ELISpot. Research can be challenging. We love to support your quest for answers. Please contact us, by phone, via e-mail, social media or in our forum, and we will do our best to assist you.

Monoclonal antibodies ELISpot FluoroSpot ELISA Spot analysis
Details about Mabtech AB
Frequently Asked Questions about Mark Bissue
Mark Bissue currently works for Mabtech.
Mark Bissue's role at Mabtech is network admin.
Mark Bissue's email address is ***@mabtech.com. To view Mark Bissue's full email address, please signup to ConnectPlex.
Mark Bissue works in the Research industry.
Mark Bissue's colleagues at Mabtech AB are Francis Shrago, Shabeeb Tv, Birbol Kurmi, Tetiana Khablo, Tiago Carlos, Julia Gustavsson, Jesper Larsson and others.
Mark Bissue's phone number is N/A
See more information about Mark Bissue